Trial intelligence / Profile preview

Simvastatin with Irinotecan/Cisplatin in ED-SCLC

NCT00452634Phase 2Completed

Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Start
Apr 2006
Primary completion
Nov 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of simvastatin in small cell lung cancer (SCLC), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Apr 2006; status: completed.

02

Drugs

simvastatin
03

Conditions

small cell lung cancer (SCLC)

Beyond the preview

Go deeper on NCT00452634.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00452634.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call